© 2021 Boise State Public Radio

For assistance accessing our public files, please contact us at boisestatepublicradio@boisestate.edu or call (208) 426-3663.
WebHeader_3.png
NPR in Idaho
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
What is the single most important question about COVID-19 you think needs to be answered? Submit it for a special Idaho Matters Doctors Roundtable in English and Spanish.

COVID-19 antiviral drugs could save lives — but will Americans be able to access them?

New York's Tenement Museum. (Robin Young/Here & Now)
New York's Tenement Museum. (Robin Young/Here & Now)

There’s an emerging new tool in the kit to fight COVID-19: anti-viral pills with great promise to make cases milder, avoiding hospitalizations and deaths.

The two antivirals — from Merck and Pfizer — are pending authorization from the Food and Drug Administration. If authorized for emergency use, the pills should largely be free to patients. But will it be easy to access them?

Lev Facher, Washington correspondent at STAT, explains.

This article was originally published on WBUR.org.

Copyright 2021 NPR. To see more, visit https://www.npr.org.